Juravinski Cancer Clinic; Clinical Trials Department

Hamilton, Ontario L8V 5C2

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Leukemia, Myeloid, Acute

Studies at this site

• A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer — Stopped early
• A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) — Stopped early